Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02ZPN
|
||||
Former ID |
DIB006616
|
||||
Drug Name |
NN-414
|
||||
Synonyms |
NNC-55-0414
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 1 diabetes [ICD9: 250; ICD10:E10] | Phase 1 | [521917] | ||
Company |
Novo Nordisk A/S
|
||||
Structure |
Download2D MOL |
||||
Formula |
C9H10ClN3O2S2
|
||||
Canonical SMILES |
S1(=O)(=O)c2c(cc(s2)Cl)NC(=N1)NC1(CC1)C
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sulfonylurea receptor 1 | Target Info | Modulator | ||
Pathway Interaction Database | FOXA2 and FOXA3 transcription factor networks | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Pancreas Function | |||||
WikiPathways | Potassium Channels | ||||
Integration of energy metabolism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.